Stock Market News

iTeos stock rises despite clinical trial setback

May 13, 2025 - 13:52
 0
iTeos stock rises despite clinical trial setback
Read More

Tags:

Previous Article

Regenxbio stock rises on FDA's priority review for MPS II therapy

Next Article

Princess Cruises cracks down on beverage package abuse

Related Posts

US stocks rise on US-UK trade agreement; earnings flurry continues

US stocks rise on US-UK trade agreement; earnings flurr...

May 8, 2025  0

China's BYD, Tsingshan scrap plans for Chile lithium plants

China's BYD, Tsingshan scrap plans for Chile lithium pl...

May 7, 2025  0

China's BYD, Tsingshan scrap plans for Chile lithium plants, newspaper reports

China's BYD, Tsingshan scrap plans for Chile lithium pl...

May 7, 2025  0